The roles of GRP78 on obesity are clear, including promoting adipogenesis and lipogenesis, promoting de novo formation of lipid droplets, negatively regulating mitochondrial biosynthesis and energy balance, causing insulin resistance, eliminating liver lipotoxicity and then improving liver steatosis. Here, HSPA5 is linked to fatty liver disease.